Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 10:55 am Sale | 2024-04-05 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 1,000 100.000% | -22,078,509 (-100.00%) | Filing History |
| 2024-02-26 5:16 pm Unchanged | 2024-02-25 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 22,079,509 26.700% | 0 (Unchanged) | Filing History |
| 2023-12-29 4:05 pm Purchase | 2023-12-28 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 22,079,509 26.700% | 1,094,533 (+5.22%) | Filing History |
| 2022-06-10 4:14 pm Purchase | 2022-06-01 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 20,984,976 26.500% | 1,951,343 (+10.25%) | Filing History |
| 2022-02-11 4:34 pm Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 654,245 1.500% | -6,101,636 (-90.32%) | Filing History |
| 2022-02-03 5:23 pm Purchase | 2022-01-24 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 19,033,633 24.500% | 1,378,422 (+7.81%) | Filing History |
| 2021-02-12 6:16 pm Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 6,755,881 17.400% | 6,755,881 (New Position) | Filing History |
| 2021-02-12 6:14 pm Unchanged | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | COLUMN GROUP L P | 6,240,638 13.100% | 0 (Unchanged) | Filing History |
| 2020-06-24 4:15 pm Purchase | 2020-06-19 | 13G | Constellation Pharmaceuticals, Inc. CNST | COLUMN GROUP L P | 6,240,638 13.100% | 41,674 (+0.67%) | Filing History |
| 2020-04-02 06:07 am Purchase | 2020-03-23 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 17,655,211 26.000% | 1,111,314 (+6.72%) | Filing History |